Cargando…
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
Introduction: Hormonal therapy in endometrial cancer (EC) is used for patients who wish to preserve fertility and for patients with advanced or recurrent disease in a palliative setting. First line hormonal therapy consists of treatment with progestins, which has a response rate of 25% in an unselec...
Autores principales: | van Weelden, Willem Jan, Massuger, Leon F. A. G., Pijnenborg, Johanna M. A., Romano, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513972/ https://www.ncbi.nlm.nih.gov/pubmed/31134155 http://dx.doi.org/10.3389/fonc.2019.00359 |
Ejemplares similares
-
The impact of adipose tissue distribution on endometrial cancer: a systematic review
por: van den Bosch, Anouk A. S., et al.
Publicado: (2023) -
The effect of progestin therapy in advanced and recurrent endometrial cancer: A systematic review and meta‐analysis
por: van Weelden, Willem Jan, et al.
Publicado: (2022) -
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms
por: van Weelden, Geert, et al.
Publicado: (2019) -
Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021) -
Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)